NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 70594-0049-02 — Polymyxin B antibiotic injection, 500,000 unitsAI (186 hospitals, 53,743–54,598 samples)
• NDC 00264-4460-10 — Intravenous 20% fat emulsionAI (248 hospitals, 53,803–54,595 samples)
• NDC 72611-0757-01 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (79 hospitals, 53,803–54,595 samples)
• NDC 00990-7715-03 — Mannitol 20% intravenous solutionAI (429 hospitals, 53,661–54,561 samples)
• NDC 63323-0806-50 — Fentanyl citrate injection, 2500 mcg per 50 mLAI (464 hospitals, 39,634–54,511 samples)
• NDC 23155-0547-31 — Ondansetron injection, 4 mg per 2 mLAI (424 hospitals, 45,817–54,466 samples)
• NDC 00409-5534-14 — Sodium bicarbonate 4.2% IV solutionAI (395 hospitals, 51,787–54,451 samples)
• NDC 00409-3300-01 — Ciprofloxacin 400 mg in dextrose IV solutionAI (505 hospitals, 52,572–54,426 samples)
• NDC 63323-0723-01 — Remifentanil injection, 1 mg vialAI (305 hospitals, 53,324–54,386 samples)
• NDC 71225-0133-02 — Dexmedetomidine IV infusion in salineAI (108 hospitals, 53,478–54,333 samples)
• NDC 42023-0187-10 — Dexmedetomidine IV infusion in salineAI (213 hospitals, 53,478–54,333 samples)
• NDC 63323-0884-01 — Sodium phosphate injection, 5 mL vialAI (513 hospitals, 51,968–54,236 samples)
• NDC 54288-0127-01 — Tetracaine 1% injection solutionAI (280 hospitals, 53,116–54,196 samples)
• NDC 23155-0661-42 — Isoproterenol injectionAI (303 hospitals, 53,328–54,192 samples)
• NDC 27505-0003-67 — Dantrolene 20 mg intravenous injectionAI (233 hospitals, 53,229–54,183 samples)
• NDC 00409-3294-51 — Potassium acetate intravenous solutionAI (350 hospitals, 53,175–54,102 samples)
• NDC 63323-0725-01 — REMIFENTANIL 5 MG INTRAVENOUS SOLUTIONAI (98 hospitals, 53,329–54,067 samples)
• NDC 67457-0118-50 — Ascorbic acid (vitamin C) injectionAI (362 hospitals, 53,238–54,066 samples)
• NDC 64253-0111-30 — Sodium chloride 0.9% IV flush solutionAI (225 hospitals, 47,229–54,033 samples)
• NDC 63323-0485-01 — Lidocaine 1% injection solutionAI (437 hospitals, 48,753–54,027 samples)
• NDC 00054-3505-47 — Lidocaine 4% topical solutionAI (694 hospitals, 52,185–53,994 samples)
• NDC 60793-0705-05 — Topical bovine thrombin spray, 5,000 unitsAI (410 hospitals, 53,024–53,933 samples)
• NDC 63323-0659-03 — Indomethacin 1 mg powder vial for solutionAI (591 hospitals, 53,044–53,899 samples)
• NDC 43066-0565-12 — Dexmedetomidine in sodium chloride IV solutionAI (155 hospitals, 53,057–53,894 samples)
• NDC 63323-0485-57 — Xylocaine 1% injection solutionAI (496 hospitals, 48,649–53,788 samples)
• NDC 00409-3294-61 — Potassium acetate intravenous solutionAI (224 hospitals, 53,046–53,784 samples)
• NDC 00409-2051-05 — Ketamine 100 mg/mL injectionAI (714 hospitals, 51,415–53,755 samples)
• NDC 17478-0510-02 — Physostigmine 1 mg/mL solution, 2 mL ampuleAI (446 hospitals, 52,980–53,754 samples)
• NDC 00703-2056-01 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (144 hospitals, 52,885–53,722 samples)
• NDC 71225-0133-01 — Dexmedetomidine IV infusion in salineAI (130 hospitals, 52,884–53,712 samples)
• NDC 72485-0109-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (73 hospitals, 52,884–53,712 samples)
• NDC 72485-0109-05 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (96 hospitals, 52,884–53,712 samples)
• NDC 70121-1585-01 — VERAPAMIL 2.5 MG/ML INTRAVENOUS SOLUTIONAI (108 hospitals, 52,884–53,712 samples)
• NDC 00338-1130-04 — Intravenous amino acid nutrition solutionAI (160 hospitals, 52,924–53,662 samples)
• NDC 409427602 — Lidocaine 1% solution, 50 mL vialAI (144 hospitals, 53,174–53,642 samples)
• NDC 16729-0298-05 — Ondansetron hydrochloride 40 mg/20 mL injectionAI (432 hospitals, 49,515–53,637 samples)
• NDC 14789-0011-07 — Isoproterenol 0.2 mg/mL injectionAI (89 hospitals, 52,876–53,632 samples)
• NDC 23155-0661-31 — Isoproterenol injection solutionAI (202 hospitals, 52,874–53,612 samples)
• NDC 25021-0669-20 — Cisatracurium 10 mg/mL intravenous solutionAI (89 hospitals, 52,874–53,612 samples)
• NDC 72485-0113-01 — Isoproterenol injection 0.2 mg/mLAI (109 hospitals, 52,874–53,612 samples)
• NDC 00409-4888-06 — Sodium chloride 0.9% injection, preservative-freeAI (251 hospitals, 46,112–53,528 samples)
• NDC 67457-0228-05 — Rocuronium injection for muscle relaxation during surgeryAI (429 hospitals, 51,763–53,401 samples)
• NDC 67457-0198-99 — remifentanil 2 mg intravenous solutionAI (150 hospitals, 52,695–53,352 samples)
• NDC 00143-9162-10 — Vancomycin 1 g intravenous injectionAI (462 hospitals, 51,911–53,279 samples)
• NDC 49471-0001-05 — Benzylpenicilloyl polylysine skin test solutionAI (313 hospitals, 52,493–53,231 samples)
• NDC 00781-3040-72 — Pyridostigmine bromide injectionAI (459 hospitals, 52,563–53,229 samples)
• NDC 23155-0345-43 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (234 hospitals, 50,886–53,226 samples)
• NDC 00641-6247-01 — Fentanyl (preservative-free) 50 mcg/mL injectionAI (313 hospitals, 38,193–53,205 samples)
• NDC 00409-2051-15 — Ketamine hydrochloride injection 100 mg/mLAI (377 hospitals, 50,897–53,138 samples)
• NDC 00409-4713-42 — Lidocaine 1% numbing injectionAI (238 hospitals, 48,293–53,009 samples)